Evidence map›Paper›PMID 34704352›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

Intrapleural transplantation of allogeneic pancreatic islets achieves glycemic control in a diabetic non-human primate.

Ji Lei, Alexander Zhang, Hongping Deng, Zhihong Yang, Cole W Peters, Kang M Lee, Zhenjuan Wang, Ivy A Rosales, Charles G Rickert, James F Markmann

Open access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Mesenchymal stem cell conditioned medium improves hypoxic injury to protect islet graft function.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ji LeiCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-7704-2370
Alexander ZhangCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Hongping DengCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Zhihong YangCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Cole W PetersCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Kang M LeeCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Zhenjuan WangCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Ivy A RosalesDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-0621-3202
Charles G RickertCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-0994-3999
James F MarkmannCenter for Transplantation Science, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-2762-6535
Harvard University · US

Funding

Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KAHN, BARBARA B. · 2000 to 2019
$31.4M
NIDDK NIH HHS P30 DK057521
6 · The paper itself

Abstract

Clinical islet transplantation has relied almost exclusively on intraportal administration of pancreatic islets, as it has been the only consistent approach to achieve robust graft function in human recipients. However, this approach suffers from significant loss of islet mass from a potent immediate blood-mediated inflammatory response (IBMIR) and a hypoxic environment. To avoid these negative aspects of the portal site, we explored an alternative approach in which allogeneic islets were transplanted into the intrapleural space of a non-human primate (NHP), treated with an immunosuppression regimen previously reported to secure routine survival and tolerance to allogeneic islets in NHP. Robust glycemic control and graft survival were achieved for the planned study period of >90 days. Our observations suggest the intrapleural space provides an attractive locale for islet transplantation due to its higher oxygen tension, ability to accommodate large transplant tissue volumes, and a lack of IBMIR-mediated islet damage. Our preliminary results reveal the promise of the intrapleural space as an alternative site for clinical islet transplantation in the treatment of type 1 diabetes.

Indexed as

Diabetes Mellitus, Type 1Hematopoietic Stem Cell TransplantationIslets of LangerhansIslets of Langerhans TransplantationAnimalsGlycemic ControlGraft SurvivalPrimatesanimal models: nonhuman primatediabetesislet transplantationtranslational research/science

Identifiers

PMID34704352
PMCPMC8897220
OpenAlexW3210758109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.